Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Schedule To Prepare Bard PowerPort Lawsuits for Bellwether Trials To Be Proposed by Parties Joint plans for preparing the first Bard PowerPort lawsuits for bellwether trials must be submitted by March 18. February 27, 2025 Irvin Jackson Add Your Comments The U.S. District Judge presiding over all federal Bard PowerPort lawsuits wants lawyers involved in the case to submit a joint proposal next month, which will detail plans for getting the first early “bellwether” test cases ready for trial, which will help determine how juries may respond to certain allegations that will be repeated throughout the litigation. C.R. Bard and its parent company, Becton Dickinson & Company, currently face more than 1,000 product liability lawsuits over problems with its PowerPort port catheter products, which are totally implantable vascular access devices (TIVADs) used to deliver chemotherapy and other medications directly into a patient’s bloodstream. It includes an injection port site, where the needle is inserted, and a polyurethane catheter tube that delivers the fluids into the body. However, each lawsuit raises similar allegations that the implants are prone to degrade and fracture inside the body, often leading to severe and life-threatening port catheter fractures or port catheter infections, which may result in the need for revision surgery to remove the failed device. Port Catheter Lawsuit DID YOU OR A LOVED ONE RECEIVE AN IMPLANTABLE PORT CATHETER? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Port Catheter Lawsuit DID YOU OR A LOVED ONE RECEIVE AN IMPLANTABLE PORT CATHETER? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Since August 2023, claims brought throughout the federal court system have been centralized and consolidated into a Bard PowerPort lawsuit MDL, or multidistrict litigation, with U.S. District Judge David G. Campbell presiding over coordinated discovery and pretrial proceedings in the District of Arizona. To help the parties evaluate the relative strengths and weaknesses of their claims, and evaluate how juries may respond to certain evidence and testimony that will be repeated throughout the lawsuits, Judge Campbell has indicated that a series of early bellwether test trials will be held in the MDL. This process began with the selection of a group of 24 Bard PowerPort bellwether cases in December 2023, which have been going through case-specific discovery over the past year. Then, late last year Bard PowerPort lawyers narrowed that list to 15 claims that are eligible for trial, which are now going through the next phase of discovery. The Court previously indicated that all discovery must be completed in those claims by January 31, 2025, with a final group of six potential trial picks selected by early March 2025. However, Judge Campbell recently agreed to extend deadlines, giving the parties until mid-April 2025 to choose their final Bard PowerPort trial cases. If the parties are unable to agree on the selections, they have each been directed to file a proposal with the court by April 14, 2025, together with a memorandum explaining their selections and why they oppose the cases proposed by the other side. Judge Campbell will then decide the final “Bellwether Group 1” claims, which will go through final trial preparations. In a follow-up case management order (PDF) issued on February 24, Judge Campbell announced he will hold a case management conference on March 20, and has ordered the parties to file a joint memorandum at least two days before the meeting, detailing their proposed schedule for bellwether-specific discovery, motions to exclude expert witnesses from testifying at trial and motions for summary judgment. The order came after a case management conference held on February 20, which also included discussions on potential replacement cases for the discovery pool, updates on depositions, and the completion of Plaintiff Profile Forms. While the outcomes of these early bellwether trials will not have any binding impact on other claims pending in the MDL or state courts, they will be closely watched by lawyers involved in the litigation and the average jury awards are expected to have a major impact on future Bard PowerPort lawsuit settlement negotiations, which will be necessary to avoid hundreds of individual claims being set for trial in the coming years. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Bard, Bard PowerPort, Catheter, Deep Vein Thrombosis, Embolism, Fracture, Infection, PowerPort, PowerPort MDL Find Out If You Qualify for Port Catheter Compensation More Bard PowerPort Lawsuit Stories Bard PowerPort Lawsuit MDL Tops 2,000 Cases September 17, 2025 Bard PowerPort Lawsuit Bellwether Trials Set To Begin March 2, 2026 August 26, 2025 Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth August 8, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermLinkedInThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (Posted: today) Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025) Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (Posted: yesterday) A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children. MORE ABOUT: ROBLOX LAWSUITLawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (09/11/2025)Roblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025) Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: 2 days ago) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth August 8, 2025
Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (Posted: today) Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)
Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (Posted: yesterday) A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children. MORE ABOUT: ROBLOX LAWSUITLawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (09/11/2025)Roblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025)
Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: 2 days ago) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)